Mar 11, 2020
IDEAYA Biosciences and Cancer Research UK Announce Expanded Research Collaboration for PARG, a DDR-Based Synthetic Lethality Target, Evaluating DNA Replication Vulnerabilities
Nov 21, 2019
Azeria Therapeutics Announces £32.0 Million Series B Financing
Oct 24, 2019
Sixth Element Capital and Cancer Research UK Beatson Institute Announce Major Collaboration to Develop Novel RAS Inhibitors
Oct 23, 2019
BioInvent Signs Manufacturing Agreement With Cancer Research UK Expected to Generate Approximately SEK 30 Million (~$3 Million)
May 24, 2019
Cancer Research UK Cambridge Institute Acquires the World's First Multispectral RSOM in Vivo Imaging System
Apr 01, 2019
Sagard Healthcare Royalty Partners and Newcastle University, UK Announce the Monetization of Royalty Interest in Cancer Drug, Rubraca
Apr 01, 2019
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
Mar 28, 2019
ArcherDX announces collaboration with University College London to Investigate the Novel Use of Cell-Free Circulating Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients
Nov 13, 2018
Azeria Therapeutics Announces Appointment of Dr Julian Blagg DPhil. FRSC as VP Drug Discovery
Sep 04, 2018
Azeria Therapeutics, the World's First Pioneer Factor Drug Discovery Company, Announces Series A Investment from Sixth Element Capital
Mar 13, 2018
IDEAYA Biosciences and Cancer Research UK Announce Partnership Agreement to Develop Small Molecule Inhibitors of PARG
Nov 06, 2017
STORM Therapeutics Strengthens Board with Appointment of Professor Paul Workman, President and CEO of The Institute of Cancer Research
Jun 08, 2017
Cancer Research UK Selects Spinnaker Support for Siebel CRM Support